Vectors derived from viruses, including lentivirus, adeno-associated virus, and adenovirus, have shown promise for use as gene therapy delivery vehicles, although their small genome packaging capacity ...
In recent years, we have seen rapid growth in the development of adeno-associated virus (AAV)-mediated gene therapy products that target fatal and highly debilitating diseases. Growth is evident in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results